Zobrazeno 1 - 10
of 65
pro vyhledávání: '"Alberto Francisco Rubio Guerra"'
Publikováno v:
Revista Colombiana de Nefrología, Vol 10, Iss 1 (2023)
Contexto: el ácido úrico es el producto final de la degradación de las purinas en los primates, en condiciones normales es un agente antioxidante endógeno y participa en varias vías fisiológicas, sin embargo, cuando los niveles séricos de urat
Externí odkaz:
https://doaj.org/article/61770138d4a5490e8c654610e5743522
Publikováno v:
Drugs in Context, Vol 7, Pp 1-9 (2018)
Hypertension is a major preventable risk factor for atherosclerosis and ischemic heart disease. Although modern and effective antihypertensive drugs are available, most patients remain with a suboptimal blood pressure control. Most hypertensive patie
Externí odkaz:
https://doaj.org/article/69712bfb504f4c70aeba53c3a96c6933
Publikováno v:
Integrated Blood Pressure Control, Vol 2010, Iss default, Pp 125-132 (2010)
Alberto Francisco Rubio-Guerra1, Hilda Vargas-Robles2, Luz Maria Ramos-Brizuela1, Bruno Alfonso Escalante-Acosta21Metabolic Clinic, Hospital General de Ticomán SS DF, Mexico; 2Department of Molecular Biomedicine, Centro de Investigacion y de Estudio
Externí odkaz:
https://doaj.org/article/20c623f2413b400f8ddd52521684a88e
Autor:
José Luis Olvera-Gómez, César Iván Elizalde-Barrera, José Juan Lozano-Nuevo, Alberto Francisco Rubio-Guerra
Publikováno v:
Diabetes Research and Clinical Practice. 153:49-54
Aims To evaluate the clinical accuracy of novel indices visceral adiposity index (VAI) and body adiposity index (BAI) to identify patients with impaired fasting glucose (IFG) and compare with its individual components and other obesity indicators. Me
Autor:
Germán Vargas-Ayala, Alberto Francisco Rubio-Guerra, Jorge Luis Narváez-Rivera, Daniel R. Benítez-Maldonado, Karla C Arana-Pazos, Carolina Guerrero-García
Publikováno v:
Nefrología Latinoamericana. 16
Autor:
Rolando Hernández-Muñoz, Rebeca Pérez-Cabeza de Vaca, Rafael Trujillo-Cortés, Mani A. Vannan, Paul Mondragón-Terán, Rocío Aceves-Millán, Juan Ángel Peraza-Zaldivar, Julieta D Morales-Portano, Alberto Francisco Rubio-Guerra, Alberto Melchor-López, Lilia Amezcua-Gómez, Carlos Haroldo Ixcamparij-Rosales, Rogelio Robledo-Nolasco, Juan Antonio Suárez-Cuenca
Publikováno v:
The International Journal of Cardiovascular Imaging
The present study aimed to compare echocardiography measurements of epicardial adipose tissue (EAT) thickness and other risk factors regarding their ability to predict adverse cardiovascular outcomes in patients with coronary artery disease (CAD). Ou
Correlación entre el grosor de la grasa epicárdica y los marcadores bioquímicos de riesgo metabólico
Autor:
Alberto Francisco Rubio-Guerra, Jorge Luis Narváez-Rivera, Daniel R. Benítez-Maldonado, Saúl Huerta-Ramírez, Karla C Arana-Pazos, José Juan Lozano-Nuevo
Publikováno v:
Medicina Clínica. 151:236-238
Resumen Introduccion y objetivo La grasa epicardica se asocia a riesgo cardiovascular y aterosclerosis, y puede ser medida en forma fiable por ecocardiografia. Nuestro objetivo es evaluar si existe asociacion entre el grosor de la grasa epicardica (G
Autor:
José Juan Lozano-Nuevo, Saúl Huerta-Ramírez, Karla C Arana-Pazos, Alberto Francisco Rubio-Guerra, Jorge Luis Narváez-Rivera, Daniel R. Benítez-Maldonado
Publikováno v:
Medicina Clínica (English Edition). 151:236-238
Introduction and objective Epicardial fat has been associated with increased cardiovascular risk and the development of atherosclerosis. Transthoracic echocardiography provides a reliable measurement of epicardial fat thickness (EFT). The aim of this
Autor:
Alberto Francisco Rubio-Guerra, Germán Vargas-Ayala, Saúl Huerta-Ramírez, Angélica Paniagua-Pérez, Andrés Ledesma-Velázquez, David Castro-Serna
Publikováno v:
Cirugía y Cirujanos. 86
Background Metabolic syndrome is a condition that predisposes to cardiovascular disease and diabetes mellitus. In addition, it can have effects over neoplastic pathologies, liver and pulmonary function. Our objective is to analyze the effect of the m
Autor:
Feliciano Tamay-Cach, A.S. Valdez-Guerrero, J. C. Quintana-Pérez, J.L. Rodríguez-Bazan, M. Martínez-Venegas, L. Del Valle-Mondragon, Monica G. Arellano-Mendoza, Alberto Francisco Rubio-Guerra
Publikováno v:
Diabetes research and clinical practice. 155
Type 2 diabetes (T2D), which causes many adverse effects such as endothelial dysfunction and cardiovascular disease, affects approximately 425 million people worldwide. However, about half have not yet been diagnosed. For what is recommended the use